JPMorgan Lowers Corteva to Neutral, Cites Valuation Constraints
JPMorgan has downgraded Corteva from Overweight to Neutral, arguing the stock's current price already reflects much of the upside and that valuation levers are limited until agricultural risks and the planned separation of the seed and crop protection businesses become clearer. The bank adjusted its price target slightly higher after lifting consol…